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Background: A frame-shift mutation in the flagellum motor gene motB coding for the chemotaxis MotB protein of
Burkholderia mallei has been utilized to design a conventional duplex PCR assay with fluorescent labelled primers.
Findings: Species specificity was tested with a panel of 13 Burkholderia type strains. A total of 41 B. mallei field
strains, 36 B. pseudomallei field strains, and 1 B. thailandensis field strain from different geographic regions were
tested and correctly identified. Testing of 55 non-Burkholderia bacterial species revealed 100% specificity of the
assay. The minimum detection limit was 1 pg DNA or 160 GE for B. mallei and 130 GE for B. pseudomallei, respectively.
Conclusions: This assay enables the clear distinction between B. mallei and B. pseudomallei/B. thailandensis.
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Despite Burkholderia mallei, B. pseudomallei and B.
thailandensis being genetically closely related Gram nega-
tive bacteria, they display significant differences in patho-
genicity and habitat. B. mallei, a facultative intracellular,
non-motile, equine pathogen, is the causative agent of
glanders, a highly contagious and frequently fatal zoonotic
disease of the upper respiratory tract and lungs [1]. The
disease has a 95% case fatality rate in untreated humans
with septicaemia and a 50% case fatality rate in antibiotic
treated individuals [1].
B. pseudomallei, a facultative intracellular, motile
bacterium found in contaminated water and soil, is the
etiological agent of melioidosis, an infectious disease in
man and animal in the tropics [2]. The clinical picture
in animals and humans resembles that of glanders in
horses. Human infection usually develops after inhalation,
ingestion, or cutaneous uptake of the pathogen [2,3]. Meli-
oidosis has a case fatality rate of 39.5%, and untreated
septicaemia is fatal in up to 80% of cases [4]. Both B.
mallei and B. pseudomallei are considered potential
bioweapons and are listed as category B biothreat agents* Correspondence: lisa.sprague@fli.bund.de
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[5]. B. thailandensis is generally considered a weakly
pathogenic, motile soil bacterium, rarely causing disease
in man or animal [6]. Glanders and melioidosis may cause
diagnostic problems in endemic regions because of their
clinical, morphologic and genetic similarity, and even
more so in non-endemic countries, due to the lack of
awareness of these diseases. In order to initiate appro-
priate patient treatment, rapid species identification is
necessary, especially in view of the intrinsic resistance of
both agents to many commonly used antibiotics and their
differing susceptibilities [7,8].
Based on the results from a previous study [9], a
frame-shift mutation in the flagellum motor gene motB
coding for the chemotaxis MotB protein [GenBank:
BMA2861] of B. mallei (ATCC 23344) was utilized to
design a simple conventional duplex PCR assay with
fluorescent labelled primers enabling the distinction
between B. mallei and B. pseudomallei/B. thailandensis.
Bacterial strains were obtained from the strain collection
of the National and OIE Reference Laboratory for
Glanders at the Friedrich-Loeffler-Institute in Jena, Germany
(Tables 1 and 2). All Burkholderia strains were cultured
at 37°C on calf blood agar containing 3% (v/v) glycerol.tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Panel of Burkholderia mallei and B. pseudomallei
field strains used for validation
Origin B. mallei B. pseudomallei
Africa - 2
Arabian Peninsula 3 -
Asia - 1
East Asia 1 4
South Asia 17 5
Southeast Asia - 13
Europe 3 4
Indonesia 1 -
South America 5 2
Transcontinental Europe/Asia 2 -
Unknown 9 5
Total 41 36
Table 2 Panel of non-Burkholderia strains used for specificity
Species Strain
Actinobacillus pleuropneumoniae ATCC 27088
Bacillus atrophaeus ATCC 9372
Bacillus brevis ATCC 8246
Bacillus cereus ATCC 10876
Bacillus megaterium DSM 90
Bacillus mycoides ATCC 6462
Bacillus subtilis ATCC 6633
Bacillus thuringiensis ATCC 10792
Bartonella henselae DSM 28221
Bartonella quintana DSM 21441
Bordetella bronchiseptica ATCC 19395
Brucella abortus ATCC 23448
Brucella melitensis ATCC 23456
Brucella suis ATCC 23444
Campylobacter coli DSM 4689
Campylobacter jejuni subsp. jejuni DSM 4688
Chlamydia abortus 07 DC0059
Chlamydia pecorum 06 DC0055
Chlamydia psittaci C1/97
Clostridium baratii ATCC 25782
Clostridium botulinum A NCTC 7272
Clostridium botulinum B NCTC 7273
Escherichia coli DSM 30083
Francisella tularensis sub. holarctica LVS
Francisella tularensis sub. tularensis FSC 237 (SchuS4)
Haemophilus influenzae ATCC 9006
Klebsiella pneumoniae subsp. pneumoniae DSM 30104
Lactobacillus ruminis DSM 20403
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Genomic DNA was prepared from culture material
using the High Pure PCR Template Preparation Kit
according to the manufacturer’s instructions (Roche,
Mannheim, Germany). All DNA samples were quantified
using a NanoDrop 1000 spectrophotometer (Fisher
Scientific, Schwerte, Germany). The duplex polymerase
chain reaction (PCR) was designed using the forward pri-
mer MBF04 (5′- CGTCAAGCGGGTGAACCA -3′), the
6-FAM labelled reverse primer MBR04-FAM (5′-6-FAM-
GTCGTCCTCGCTCTTTCGC -3′), and the ATTO565
labelled reverse primer MBR10-ATTO565 (5′-ATTO565-
GTCCTCGCTCTTCTTCGCG-3′). Primers were designed
with the Genious software package (Ver. 6.1), to generate a
specific 6-FAM labelled 326 bp DNA fragment for B. mallei
and an ATTO565 labelled 325 bp DNA fragment for
B. pseudomallei/B. thailandensis, respectively. Labelledtesting
Species Strain
Legionella pneumophila sub. pneumophila DSM 7513
Mannheimia haemolytica ATCC 33396
Ochrobactrum anthropi CCUG 1047
Oligella urethralis DSM 7531
Pasteurella multo ssp.multo ATCC 43137
Pasteurella multocida DSM 5281
Proteus mirabilis DSM 4479
Pseudomonas aeruginosa ATCC 9027
Pseudomonas alcaligenes ATCC 14909
Pseudomonas fluorescens ATCC 13525
Pseudomonas polymyxa ATCC 842
Pseudomonas putida ATCC 12633
Rhodococcus equi DSM 20307
Salmonella enteritidis 147 (95)
Salmonella typhumirium 9098 (221)
Staphylococcus aureus subsp. aureus DSM 6732
Stenotrophomonas maltophilia ATCC 13637
Streptococcus agalactiae DSM 6784
Streptococcus equi subsp. equi ATCC 9528
Streptococcus equi subsp. zooepidemicus ATCC 700400
Streptococcus equinus DSM 20558
Streptococcus parauberis DSM 6631
Taylorella equigenitalis DSM 10668
Yersinia enterocolitica subsp. enterocolitica ATCC 9610
Yersinia enterocolitica subsp. enterocolitica DSM 9499
Yersinia enterocolitica subsp. palearctica DSM 13030
Yersinia pseudotuberculosis IP32953
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Switzerland), the unlabelled primer from Jena Bioscience
(Jena, Germany). PCR was conducted in a 20 μL reaction
containing 0.3 μM of the primers (MBF04, MBR04-
FAM, and MBR10-ATTO565), 1 × 5-Prime HotMaster-
Mix (VWR, Darmstadt, Germany), 2.5% DMSO and 10 ng
template (total DNA). The PCR was performed in a
Mastercycler pro S™ (Eppendorf, Germany) under the fol-
lowing conditions: initial denaturation at 95°C for 1 min;
40 cycles at 95°C for 10 s, 63°C for 15 s, 70°C for 30 s, and
the final extension at 70°C for 5 min. 13.3 μL PCR reac-
tion mixed with 2.7 μL 6 × Loading Dye (Fermentas,
Schwerte, Germany) were analysed by electrophoresis
on a 1.25% agarose gel (wt/vol) at 9 V/cm for 40 min. Im-
ages were captured after an exposure period of 30 s for
each LED/filter set using the G-Box EF2 Gel Docu-
mentation System (Syngene Europe, Cambridge, UK):
Blue-LED/Filt525 and Green-LED/Filt605 for the visu-
alisation of 6-FAM and ATTO565 labelled PCR prod-
ucts, respectively. For optional ethidium bromide imaging
(302 nm UV illuminator/FiltUV), the gel was stained after
capturing the 6-FAM/ATTO565 images. Fragment sizes
(326/327 bp) and correct labelling (6-FAM/ATTO565) of
the amplicons were confirmed by means of capillary
electrophoresis using a Genetic Analyzer 3130 with a
G5 filter set (Applied Biosystems/Hitachi, Darmstadt,
Germany). Species specificity was tested with a panel
of 13 Burkholderia type strains. Additionally, a total of 41
B. mallei field strains from equines, 36 B. pseudomallei
field strains from human and environmental origin,
and one B. thailandensis field strain, all from different
geographic regions were tested and correctly identified
(Table 1). Testing of 55 non-Burkholderia bacterial species
revealed 100% specificity of the assay (Table 2). The mini-
mum detection limit was 1 pg DNA or 160 genome equiv-
alents (GE) for B. mallei and 130 GE for B. pseudomallei,
respectively. In order to compare the sensitivity of our
assay with other assays used by the National and OIE Ref-
erence Laboratory for Glanders, several clinical B. mallei
samples were tested by a conventional fliP PCR [10] and a
real time PCR assay targeting fliC [11]. Despite the lower
sensitivity we determined for our assay, it revealed com-
parable sensitivity to the conventional fliP PCR and a
higher sensitivity than the real time fliC assay in the tested
clinical samples (Additional file 1).
Fluorescent primers are widely used in real time PCR
technology and several highly sophisticated and elegant
PCR assays have been developed for the identification
and differentiation of B. mallei and B. pseudomallei and
other Burkholderia species in the past few years [12].
This study describes the design of a simple conventional
duplex PCR with fluorescent labelled primers for amplify-
ing species-specific amplicons of B. mallei and B. pseudo-
mallei/B. thailandensis, respectively. These closely relatedspecies can cause considerable problems during the iden-
tification process in the laboratory as colony characteris-
tics and routine biochemical tests are not sufficiently
discriminative for species identification. The benefit of this
assay is not only the unambiguous identification of B.
mallei and the closely related species B. pseudomallei and
B. thailandensis by fluorescence image capturing but also
the possibility of detecting the B. mallei/pseudomallei/
thailandensis complex on a standard ethidium bromide
stained agarose gel.
Additional file
Additional file 1: Comparison of the motB PCR assay to the
conventional fliP and real time fliC PCR assays in clinical samples
(Burkholderia type strains ATCC 23343 T, ATCC 23344T).
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